243 related articles for article (PubMed ID: 29980571)
1. Erbin Suppresses KSR1-Mediated RAS/RAF Signaling and Tumorigenesis in Colorectal Cancer.
Stevens PD; Wen YA; Xiong X; Zaytseva YY; Li AT; Wang C; Stevens AT; Farmer TN; Gan T; Weiss HL; Inagaki M; Marchetto S; Borg JP; Gao T
Cancer Res; 2018 Sep; 78(17):4839-4852. PubMed ID: 29980571
[TBL] [Abstract][Full Text] [Related]
2. PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice.
Li X; Stevens PD; Liu J; Yang H; Wang W; Wang C; Zeng Z; Schmidt MD; Yang M; Lee EY; Gao T
Gastroenterology; 2014 May; 146(5):1301-12.e1-10. PubMed ID: 24530606
[TBL] [Abstract][Full Text] [Related]
3. Tax1 enhances cancer cell proliferation via Ras-Raf-MEK-ERK signaling pathway.
Song C; Wang W; Li M; Liu Y; Zheng D
IUBMB Life; 2009 Jun; 61(6):685-92. PubMed ID: 19472191
[TBL] [Abstract][Full Text] [Related]
4. Erbin inhibits RAF activation by disrupting the sur-8-Ras-Raf complex.
Dai P; Xiong WC; Mei L
J Biol Chem; 2006 Jan; 281(2):927-33. PubMed ID: 16301319
[TBL] [Abstract][Full Text] [Related]
5. Erbin suppresses the MAP kinase pathway.
Huang YZ; Zang M; Xiong WC; Luo Z; Mei L
J Biol Chem; 2003 Jan; 278(2):1108-14. PubMed ID: 12379659
[TBL] [Abstract][Full Text] [Related]
6. KRAS Mutation-Responsive miR-139-5p inhibits Colorectal Cancer Progression and is repressed by Wnt Signaling.
Du F; Cao T; Xie H; Li T; Sun L; Liu H; Guo H; Wang X; Liu Q; Kim T; Franklin JL; Graves-Deal R; Han W; Tian Z; Ge M; Nie Y; Fan D; Coffey RJ; Lu Y; Zhao X
Theranostics; 2020; 10(16):7335-7350. PubMed ID: 32641995
[No Abstract] [Full Text] [Related]
7. Oncogenic mutation in RAS-RAF axis leads to increased expression of GREB1, resulting in tumor proliferation in colorectal cancer.
Kochi M; Hinoi T; Niitsu H; Miguchi M; Saito Y; Sada H; Sentani K; Sakamoto N; Oue N; Tashiro H; Sotomaru Y; Yasui W; Ohdan H
Cancer Sci; 2020 Oct; 111(10):3540-3549. PubMed ID: 32629543
[TBL] [Abstract][Full Text] [Related]
8. Loss of Apc allows phenotypic manifestation of the transforming properties of an endogenous K-ras oncogene in vivo.
Sansom OJ; Meniel V; Wilkins JA; Cole AM; Oien KA; Marsh V; Jamieson TJ; Guerra C; Ashton GH; Barbacid M; Clarke AR
Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14122-7. PubMed ID: 16959882
[TBL] [Abstract][Full Text] [Related]
9. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
10. Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signaling.
Nath D; Li X; Mondragon C; Post D; Chen M; White JR; Hryniewicz-Jankowska A; Caza T; Kuznetsov VA; Hehnly H; Jamaspishvili T; Berman DM; Zhang F; Kung SHY; Fazli L; Gleave ME; Bratslavsky G; Pandolfi PP; Kotula L
Cell Commun Signal; 2019 Sep; 17(1):120. PubMed ID: 31530281
[TBL] [Abstract][Full Text] [Related]
11. APC loss-induced intestinal tumorigenesis in Drosophila: Roles of Ras in Wnt signaling activation and tumor progression.
Wang C; Zhao R; Huang P; Yang F; Quan Z; Xu N; Xi R
Dev Biol; 2013 Jun; 378(2):122-40. PubMed ID: 23570874
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA‑143‑3p suppresses cell growth and invasion in laryngeal squamous cell carcinoma via targeting the k‑Ras/Raf/MEK/ERK signaling pathway.
Zhang F; Cao H
Int J Oncol; 2019 Feb; 54(2):689-701. PubMed ID: 30535502
[TBL] [Abstract][Full Text] [Related]
13. Desmoglein-1/Erbin interaction suppresses ERK activation to support epidermal differentiation.
Harmon RM; Simpson CL; Johnson JL; Koetsier JL; Dubash AD; Najor NA; Sarig O; Sprecher E; Green KJ
J Clin Invest; 2013 Apr; 123(4):1556-70. PubMed ID: 23524970
[TBL] [Abstract][Full Text] [Related]
14. KSR1- and ERK-dependent translational regulation of the epithelial-to-mesenchymal transition.
Rao C; Frodyma DE; Southekal S; Svoboda RA; Black AR; Guda C; Mizutani T; Clevers H; Johnson KR; Fisher KW; Lewis RE
Elife; 2021 May; 10():. PubMed ID: 33970103
[TBL] [Abstract][Full Text] [Related]
15. FAT4 regulates the EMT and autophagy in colorectal cancer cells in part via the PI3K-AKT signaling axis.
Wei R; Xiao Y; Song Y; Yuan H; Luo J; Xu W
J Exp Clin Cancer Res; 2019 Mar; 38(1):112. PubMed ID: 30832706
[TBL] [Abstract][Full Text] [Related]
16. DA-Raf-Mediated Suppression of the Ras--ERK Pathway Is Essential for TGF-β1-Induced Epithelial-Mesenchymal Transition in Alveolar Epithelial Type 2 Cells.
Watanabe-Takano H; Takano K; Hatano M; Tokuhisa T; Endo T
PLoS One; 2015; 10(5):e0127888. PubMed ID: 25996975
[TBL] [Abstract][Full Text] [Related]
17. Loss of periplakin expression is associated with the tumorigenesis of colorectal carcinoma.
Li X; Zhang G; Wang Y; Elgehama A; Sun Y; Li L; Gu Y; Guo W; Xu Q
Biomed Pharmacother; 2017 Mar; 87():366-374. PubMed ID: 28068625
[TBL] [Abstract][Full Text] [Related]
18. The circular RNA circ-ERBIN promotes growth and metastasis of colorectal cancer by miR-125a-5p and miR-138-5p/4EBP-1 mediated cap-independent HIF-1α translation.
Chen LY; Wang L; Ren YX; Pang Z; Liu Y; Sun XD; Tu J; Zhi Z; Qin Y; Sun LN; Li JM
Mol Cancer; 2020 Nov; 19(1):164. PubMed ID: 33225938
[TBL] [Abstract][Full Text] [Related]
19. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J
Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111
[TBL] [Abstract][Full Text] [Related]
20. A gene marker panel covering the Wnt and the Ras-Raf-MEK-MAPK signalling pathways allows to detect gene mutations in 80% of early (UICC I) colon cancer stages in humans.
Scholtka B; Schneider M; Melcher R; Katzenberger T; Friedrich D; Berghof-Jäger K; Scheppach W; Steinberg P
Cancer Epidemiol; 2009 Aug; 33(2):123-9. PubMed ID: 19679059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]